Insurance
FWD Group prices Hong Kong IPO at $4.84 for 7 July debut
FWD Group prices Hong Kong IPO at $4.84 for 7 July debut
The offering is expected to raise $445m.
Resolution Life seals first Hong Kong reinsurance deal worth $1b
The deal covers a portfolio of in-force participating whole life and annuity policies.
Howden Re launches reinsurance broking unit in Hong Kong
A managing director has been appointed to lead the treaty reinsurance operations.
Prudential adds former Swiss Re CIO Guido Fürer to board
Meanwhile, Amy Yip will step down from the Board on 31 October.
Prudential adds pet protection to travel insurance suite
The enhanced plan offers up to $1,300 (HK$10,000) for overseas pet medical costs.
YAS deploys AI to adjust premiums for Hong Kong taxis
It will initially cover around 1,000 hybrid and electric taxis.
FWD Group to offer 91.34m shares in HK listing
It’s priced at HK$38.00 (US$4.84) apiece.
AIA Hong Kong unveils life plan for HNWIs with 5.05% internal return rate
Policyholders also gain access to AIA Club Alta.
Blue Cross expands GBA healthcare access with cross-border partners
Individual and group medical insurance holders can access medical consultations.
Prudential Hong Kong begins accepting claims for histotripsy care
Histotripsy uses focused soundwaves to create microbubbles within a tumour.
FWD Hong Kong adds cross-border care via New Frontier deal
The initiative includes a cashless hospitalisation service.
Bupa Hong Kong expands network with four mainland China partners
The insurer added 69 locations in 10 mainland cities.
SingWealth sets foot in Hong Kong with new insurance brokerage licence
It aims to replicate the financial services model it has established in Singapore.
Hong Kong insurers stay stronger under new reporting standard, HKRBC
Insurers applying for transitional measures are likely to recalibrate their operations.
AXA to re-domicile Bermuda-based insurance unit to Hong Kong
The move will not affect ACRIB’s legal entity, organisational structure, or operations.
Sun Life debuts IUL product in HK to target wealthy investors
The new product links its indexed account value to the performance of a chosen index.
Commentary
The succession shift: Redesigning wealth structures for the next generation
2026 biotech playbook: Hong Kong at the centre of China’s globalisation
Navigating Hong Kong’s regulatory landscape: a challenging and rewarding endeavour